Regulation of cell migration is critical in such diverse biological processes as organogenesis, neuronal axon pathfinding, wound healing, inflammatory responses, vascular remodeling, and tumor cell dissemination (21) . Extracellular cues called attractants and repellants, which are either soluble or membrane bound, instruct cells to advance and to retreat, respectively (36, 40) . A number of chemokines, growth factors, cytokines, and other inflammatory mediators have been shown to stimulate directed cell migration, whereas a much more limited number of biological mediators have been shown to inhibit cell motility in a manner dependent on their concentration gradients. The latter include metastin (28) , Slit, semaphorins, ephrins (44) , and a lipid mediator, sphingosine 1-phosphate (S1P) (42) . S1P is a bioactive lysophospholipid that exerts a wide variety of biological activities, most of which are mediated via Edg family G protein-coupled receptors (GPCRs), including S1P 1 /Edg1, S1P 2 /Edg5/AGR16/H218, and S1P 3 /Edg3 (7, 16, 39, 43) . S1P has been demonstrated to be quite unique as an extracellular regulator of motility in that it exerts either stimulatory or inhibitory actions on cell motility (42) . These bimodal actions are apparently cell type specific; thus, S1P stimulates chemotaxis in vascular endothelial cells (22) and embryonic fibroblasts (24) , whereas it inhibits cell migration in vascular smooth muscle cells (3, 33) and melanoma cells (34) . We recently showed that this bimodal regulation by S1P is based upon a diversity of S1P receptor isotypes, which mediate either stimulatory or inhibitory regulation for cell migration (31, 42) . Thus, we found that S1P 2 acts as a repellant receptor to mediate inhibition of chemotaxis toward attractants, whereas S1P 1 and S1P 3 act as attractant receptors to mediate migration directed toward S1P. Elimination of the S1P receptor gene in mice (24) and development of a drug to target S1P receptors (4, 25) have revealed that S1P is involved in regulation of cell migration in vivo, thus contributing to morphogenesis and regulation of lymphocyte homing.
Small GTPases of the Rho family, primarily Rac, Cdc42, and Rho, are well-known regulators of actin organization and myosin motor function and thereby of cell motility (10, 14, 47) . These Rho GTPases show distinct activities on actin cytoskeletons: Rho mediates stress fiber formation and focal adhesion, while Rac and Cdc42 direct peripheral actin assembly that results in formation of lamellipodia and filopodia, respectively. Despite limitation of our understanding of intracellular signaling from the membrane to the cytoskeleton, a model has emerged from the observations in a variety of cell types that attractive extracellular cues activate Rac or Cdc42, while repulsive cues inhibit Rac or Cdc42 and stimulate Rho (9, 38, 42, 48) . In fact, the repellant receptor S1P 2 negatively regulates cellular Rac activity through mechanisms involving stimulation of a GTPase-activating protein (GAP) for Rac (31) . In contrast, the attractant receptors S1P 1 and S1P 3 mediate activation of Rac via G i (22, 31, 32) . Neither of these S1P receptors affects Cdc42 activity under our experimental conditions. Interestingly, the repellant receptor S1P 2 and the attractant receptor S1P 3 similarly mediate stimulation of cellular RhoA activity, most likely via G 12/13 . Expression of N 17 Rac, but not N 19 RhoA or C3 toxin treatment, inhibited cell migration, indicating an essential role of Rac in cell migration (31, 33) .
In the present study we explored the mechanisms by which S1P 2 receptor activation leads to Rac inhibition. The results of the present study demonstrate for the first time that inhibitory regulation of Rac by the GPCR is mediated via G 12/13 and Rho, through a downstream signaling mechanism not involving To establish CHO cells that stably express S1P 2 -G␣ fusion receptors, cells were cotransfected with pCAGGS-S1P 2 -G␣ and the neomycin resistance gene expression vector pKM3 (27) and were selected in the presence of 0.7 mg of G418 (Nacalai, Kyoto, Japan)/ml. To establish CHO-S1P 2 cells that stably express full-length G␣ protein and G␣ q -CT, CHO-S1P 2 cells were cotransfected with either pCAGGS-G␣, pCAGGS-G␣ q -CT, or the Zeocin resistance gene expression vector pCMV/Zeo (Invitrogen) and were selected in the presence of 50 g of Zeocin (Invitrogen)/ml and 0.7 mg of G418/ml. Cloned cells were isolated and tested for expression of transduced genes.
In the experiments using CHO-S1P 2 cells that express N 19 Rho or V 14 Rho, CHO-S1P 2 cells were cotransfected with either pME18S-myc-N 19 RhoA or pME18S-myc-V 14 RhoA and pCMV/Zeo and were selected in the presence of 50 g of Zeocin/ml. The Zeocin-resistant cell populations were employed in these experiments. Cells. CHO-K1 (CHO) cells, Swiss 3T3 cells, and COS7 cells were grown in Ham's F-12 (CHO) or Dulbecco's modified Eagle medium (3T3 and COS7) supplemented with 10% fetal bovine serum (Equitech-Bio, Ingram, Tex.), 100 U of penicillin/ml, and 100 g of streptomycin/ml (Wako Pure Chemicals). CHO cells that stably overexpress either S1P 1 , S1P 2 , or S1P 3 , i.e., CHO-S1P 1 , CHO-S1P 2 , and CHO-S1P 3 cells, respectively, have been described previously (13, 29, 30) and were maintained in the presence of 0.7 mg of G418/ml. Cells were treated with C3 toxin (10 g/ml) in F-12 medium containing 10% fetal bovine serum for 48 h and then in serum-free F-12 medium for a further 24 h. PTX (200 ng/ml) treatment was carried out by incubating cells in serum-free F-12 medium containing PTX for 24 h before experiments.
Transwell migration assay. Chemotactic migration of cells was measured in a modified Boyden chamber (Neuroprobe) using polycarbonate filters with 8-m pores as described in detail previously (31, 33) . In migration assays using transiently transfected cell populations, the migratory cells attached to the lower side of the membrane were subjected to stainining with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside as a substrate. The number of migratory cells staining positive with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside was determined by using a microplate reader as described above.
Determination of the activities of Rho and Rac. Pulldown assay methods to determine GTP-bound active forms of Rho and Rac have been described in detail previously (31, 33, 35) . Briefly, cell extracts were incubated with the GST-rhotekin Rho-binding domain (for determination of Rho activity) or the GST-PAK CRIB domain (for determination of Rac activity) immobilized to glutathione-Sepharose 4B beads (Pharmacia Amersham Biotech) at 4°C for 45 min, followed by three washes. Bound Rho and Rac proteins were quantitatively detected by Western blotting using specific, monoclonal antibodies against RhoA and Rac.
Western blotting, [Ca 2؉ ] i measurement, and fluorescence microscopy. Western blotting was performed as described previously (29) . The band shift of activated p42 and p44 extracellular signal-regulated kinase (ERK) was detected by Western blot analysis of total cell lysates with a mouse monoclonal anti-ERK antibody (8) . Intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) was measured as described previously (29) in Fura-2-loaded cells with a CAF-110 spectrofluorimeter (Japan Spectroscopy, Inc., Tokyo, Japan) with excitation at 340 and 380 nm and emission at 500 nm.
To evaluate actin cytoskeletons, cells were transfected as indicated 48 h before experiments and were serum starved for 24 h. After treatment with receptor agonists and/or Rho kinase inhibitors for indicated times, the cells were fixed in 3.7% formaldehyde in phosphate-buffered saline and processed as described previously (41) . F-actin was visualized with TRITC-labeled phalloidin under an inverted fluorescence microscope IX70 (Olympus, Tokyo, Japan).
Statistics. Values are presented as means Ϯ standard errors of three or more determinations and are representative of at least two independent experiments with similar results.
RESULTS

AlF 4
؊ mimics S1P 2 actions in inhibiting Rac and migration in IGF I-stimulated cells. Most of the actions of GPCRs are mediated through heterotrimeric G protein coupling. However, recent studies provide evidence that mechanisms independent of heterotrimeric G protein coupling mediate certain actions of GPCRs, which include regulation of a Na underlying GPCR-mediated inhibition of cell migration, we first investigated whether S1P 2 -mediated Rac inhibition occurs through heterotrimeric G protein coupling, and, if so, which heterotrimeric G protein mediates Rac inhibition. In CHO cells expressing the S1P 2 receptor (CHO-S1P 2 ), but not in naive CHO cells or CHO cells expressing S1P 1 or S1P 3 , S1P dose-dependently and potently inhibited IGF I-directed chemotaxis, which is a Rac-dependent process (31) . Direct stimulation of the heterotrimeric G proteins with AlF 4 Ϫ (17) dosedependently inhibited chemotaxis of CHO-S1P 2 cells toward IGF I, like S1P stimulation of the S1P 2 receptor (Fig. 1A) . AlF 4 Ϫ also mimicked the action of S1P 2 in inhibiting IGF I-induced increases in cellular amounts of a GTP-bound, active form of Rac (GTP-Rac) (Fig. 1B) and in stimulating RhoA (Fig. 1C) , ERK (Fig. 1D) , and Ca 2ϩ mobilization (data not shown). These observations strongly suggest that the heterotrimeric G protein(s) mediated inhibition of Rac and cell migration as well as the other actions of S1P 2 .
Endogenous G 12 and G 13 couple S1P 2 to inhibition of cell migration. To examine which member of the heterotrimeric G proteins is responsible for mediating suppression of cell migration, we determined the effects of specific inhibition of receptor-G protein coupling by either transient expression of C-terminal peptides (1, 11) of heterotrimeric G protein ␣ subunits (G␣-CTs) or pretreatment with PTX. Shown in Fig. 2A are Western blot analyses of the expression of G␣ s -CT, G␣ q -CT, G␣ 12 -CT, and G␣ 13 -CT. CHO-S1P 2 cells were cotransfected with one of these peptides and ␤-galactosidase (LacZ) and subjected to a migration assay (31) . As in naive CHO-S1P 2 cells (31), S1P inhibited IGF I-directed chemotaxis in vectortransfected CHO-S1P 2 cells with a bell-shaped dose-response curve and maximal inhibition at 10 Ϫ7 M (Fig. 2B ).Neither expression of any of these C-terminal peptides nor pretreatment with PTX affected chemotaxis toward IGF I in the absence of S1P (Fig. 2B) . Expression of G␣ 12 -CT or G␣ 13 -CT, but not G␣ s -CT or G␣ q -CT, specifically abolished the S1P inhibition of IGF I-directed chemotaxis. We confirmed that expression of G␣ q -CT effectively inhibited the S1P-induced increase in [Ca 2ϩ ] i , a G q -mediated response, compared to that with the vector control in S1P-expressing cells (Fig. 2C ). Inhibition of G i/o by PTX pretreatment, and expression of ␤ARK-CT, which acts as a scavenger for ␤␥ subunits (20) , to a lesser extent, rather potentiated S1P inhibition of IGF I-directed chemotaxis at lower S1P concentrations. PTX pretreatment or the expression of ␤ARK-CT substantially attenuated S1P-induced ERK activation (data not shown), confirming the effectiveness of PTX and ␤ARK at inhibiting G i . These observations are consistent with the notion that endogenously expressed G 12 and G 13 are responsible for mediating a signal Ϫ or 10 Ϫ7 M S1P for 10 min and then stimulated with IGF I (100 ng/ml) for 1 min. Cells were then subjected to a pulldown assay for GTP-Rac as described in Materials and Methods. GTP-Rac bound to the GST-PAK1 CRIB domain immobilized onto Sepharose beads was analyzed by Western blotting using an anti-Rac antibody (top), and 1/100 of total Rac present in the cell lysate is also shown to confirm loading of equal amounts of proteins (bottom). (C) AlF 4 Ϫ and S1P stimulate Rho. CHO-S1P 2 cells were stimulated with various concentrations of AlF 4 Ϫ or 10 Ϫ7 M S1P for 3 min. Cells were then subjected to a pulldown assay for GTP-RhoA as described in Materials and Methods. (D) AlF 4 Ϫ and S1P stimulate ERK1 and -2. CHO-S1P 2 cells were stimulated with various concentrations of AlF 4 Ϫ or 10 Ϫ7 M S1P for 5 min. ERK activation was determined by band shift analysis using Western blotting. that leads to inhibition of migration upon S1P stimulation of the S1P 2 receptor. It has been reported for Swiss 3T3 fibroblasts (12) that endothelin-1 (ET1) and LPA induce stress fiber formation through G 12 and G 13 , respectively. By employing Swiss 3T3 cells and these GPCR agonists, we determined the specificity of the inhibitory actions of G␣ 12 -CT and G␣ 13 -CT. We observed that expression of G␣ 13 -CT abolished LPA-induced stress fiber formation (Fig. 2Da, b , e, and f) but not ET1-induced stress fiber formation (Fig. 2Di , j, m, and n), while expression of G␣ 12 -CT abolished both ET1-and LPA-induced stress fiber formation (Fig. 2Dc, d, k, and l) . The results indicate that the G␣ 13 -CT peptide acts as a selective inhibitor for G 13 whereas the G␣ 12 -CT peptide acts as an inhibitor for both G 12 and G 13 . Together with the observation using ␤ARK-CT (Fig. 2B) , we conclude that the ␣ subunits, but not the ␤␥ dimer, of G 13 or both G 12 and G 13 mediate inhibition of migration.
Endogenous G 12 and G 13 couple S1P 2 to inhibition of Rac and stimulation of Rho. We next expressed myc-tagged G␣ 12 -CT, G␣ 13 -CT, and G␣ q -CT, and LacZ as a control, by adenovirus-mediated gene transduction in CHO-S1P 2 cells, and we determined the effects of their expression on the activities of RhoA and Rac (Fig. 3) and also on the actin cytoskeleton (Fig.  4) . Expression of the inhibitor proteins was confirmed by Western blot analysis (Fig. 3A) . Expression of any of these Cterminal peptides did not affect IGF I-induced Rac activation (Fig. 3B ) or membrane ruffling (Fig. 4) in the absence of S1P, nor did it affect S1P stimulation of ERK (Fig. 3D ), indicating that their expression did not compromise cellular activity in a nonspecific manner. Interestingly, however, expression of either G␣ 12 -CT or G␣ 13 -CT, but not G␣ q -CT or LacZ, abolished S1P inhibition of Rac activation in response to IGF I (Fig. 3B) . Expression of either G␣ 12 -CT or G␣ 13 -CT, but not G␣ q -CT, also greatly inhibited S1P-induced RhoA stimulation compared to LacZ transfection (Fig. 3C) . Consistent with the effects on Rho and Rac, expression of G␣ 12 -CT or G␣ 13 -CT, but not of G␣ q -CT or LacZ, abolished S1P suppression of peripheral actin filament assembly in response to IGF I, as well as S1P stimulation of stress fiber formation (Fig. 4) . These results are consistent with the observations on cell migration and indicate that G 12 and G 13 are responsible for mediating suppressive effects of S1P on cellular Rac activity, membrane ruffling, and cell migration in CHO-S1P 2 cells. S1P 2 -G␣ 12 and S1P 2 -G␣ 13 fusion receptors, but not S1P 2 -G␣ q , mediate inhibition of Rac and migration. Consistent with the observations showing functional coupling of S1P 2 to G 12 and G 13 (Fig. 2 to 4) , we observed coimmunoprecipitation of S1P 2 and either G 12 or G 13 from the cells coexpressing these molecules (Fig. 5A) . We further studied and compared the effects of S1P on IGF I-directed migration in CHO cells that stably expressed fusion receptors designated S1P 2 -G␣ 12 , S1P 2 -G␣ 13 , and S1P 2 -G␣ q , which have either of the full-length G␣ subunit sequences fused to the C terminus of S1P 2 (37) . In CHO cells expressing either the S1P 2 -G␣ 12 or the S1P 2 -G␣ 13 fusion receptor, S1P potently inhibited chemotaxis toward IGF I (Fig. 5B) . Adenovirus-mediated expression of G␣ 12 -CT or G␣ 13 -CT completely abolished S1P inhibition of IGF I-directed chemotaxis in cells expressing the respective fusion re-CHO-S1P 2 cells were either cotransfected with LacZ and one of the expression vectors for G␣ s -CT, G␣ q -CT, G␣ 12 -CT, G␣ 13 -CT, and ␤ARK-CT at a weight ratio of 1:2.5 or pretreated with PTX (200 ng/ml) as described in Materials and Methods. Transwell migration of transfected CHO-S1P 2 cells was determined in the presence of IGF I (100 ng/ml) and various concentrations of S1P in the lower chamber. (C) Expression of G␣ q -CT inhibits the S1P-induced [Ca 2ϩ ] i increase in S1P 2 -overexpressing CHO cells. CHO-S1P 2 cells stably expressing G␣ q -CT and CHO-S1P 2 cells expressing the vector control were stimulated by S1P at 10 Ϫ8 M, and the peak increment in the [Ca 2ϩ ] i was determined. (D) Inhibition of LPAand ET1-induced stress fiber formation by expression of G␣ 12 -CT or G␣ 13 -CT. Swiss 3T3 cells were cotransfected with pEGFP-C1 and either an expression vector for G␣ 12 -CT or G␣ 13 -CT or an empty vector at a weight ratio of 1:10. Cells were stimulated with LPA or ET1 at 10 Ϫ7 M for 10 min. F-actin was visualized with TRITC-labeled phalloidin. Arrowheads indicate transfected cells identified with GFP fluorescence. 12 -CT and G␣ 13 -CT abolishes S1P inhibition of Rac and stimulation of Rho in S1P 2 receptor-expressing cells. (A) Western blot analysis of expression of the G␣ C-terminal peptides. CHO-S1P 2 cells were infected with adenoviruses encoding myc-tagged G␣ q -CT, G␣ 12 -CT, G␣ 13 -CT, and LacZ 48 h before experiments and were subjected to Western blot analysis using an anti-myc tag antibody. (B and C) Expression of G␣ 12 -CT and G␣ 13 -CT, but not G␣ q -CT abolishes S1P inhibition of IGF I-induced Rac stimulation and S1P stimulation of Rho. CHO-S1P 2 cells that had been were infected with the adenoviruses were stimulated with IGF I (100 ng/ml) for 1 min in the presence of S1P (10 Ϫ7 M) (for the Rac assay) or with S1P (10 Ϫ7 M) for 3 min (for the Rho assay). For the Rac assay S1P was added 10 min before addition of IGF I. Cells were then subjected to a pulldown assay for GTP-Rac or GTP-RhoA. (D) Inhibition of S1P-induced ERK stimulation by PTX, but not by expression of G q -CT, G 12 -CT, or G 13 -CT. CHO-S1P 2 cells were either infected with the adenoviruses as described above or pretreated with PTX as for Fig. 2B . Cells were then stimulated with S1P (10 Ϫ7 M) for 5 min and subjected to band shift analysis. (Fig. 5C) ; however, they responded to S1P with only a marginal inhibition of cell migration (Fig. 5B) . In vector-transfected cells and cells expressing either of the three fusion receptors, IGF I similarly stimulated Rac activity (Fig. 5D) . In cells expressing either S1P 2 -G␣ 12 or S1P 2 -G␣ 13 , but not vector-transfected cells or cells expressing S1P 2 -G␣ q , S1P induced a nearly complete inhibition of Rac activation in response to IGF I, as in CHO-S1P 2 cells (Fig. 5D ). As expected, cells expressing S1P 2 -G␣ 12 or S1P 2 -G␣ 13 , but not vector-transfected cells or cells expressing S1P 2 -G␣ q , showed strong activation of RhoA in response to S1P (Fig. 5D ). These observations provided further evidence that G 12/13 coupled with S1P 2 for inhibition of Rac and migration.
FIG. 3. Adenovirus-mediated expression of G␣
Rho mediates inhibition of cellular Rac activity and migration through a mechanism not involving Rho kinase. We tested the possibility that Rho, which is an effector of G 12/13 , was involved in the signaling pathway leading to suppression of Rac activity. Pretreatment of S1P 2 -expressing cells with botulinum C3 toxin, which inactivates Rho, did not affect migration in response to IGF I; however, it completely abolished the S1P 2 -mediated inhibition of IGF I-directed migration (Fig.  6A) . Similarly, adenovirus-mediated expression of N 19 RhoA did not affect chemotaxis toward IGF I but totally abolished S1P inhibition of IGF I-directed migration (Fig. 6A) . Consistent with these observations, either C3 treatment or N 19 RhoA expression abolished S1P inhibition of IGF I-induced Rac stimulation, while these treatments did not affect Rac activation in response to IGF I alone (Fig. 6B) . On the other hand, we observed that cells that stably expressed a myc-tagged constitutively active RhoA mutant, myc-V 14 RhoA, showed reductions in both chemotaxis and Rac activation in response to IGF I, compared to vector-control cells (Fig. 6C and 6D) .
We next studied whether Rho kinase, which is one of the direct effectors of Rho (23, 46) , was involved in S1P 2 -mediated suppression of Rac activity and migration. It was previously reported that a Rho kinase inhibitor abolished V 14 Rho-induced inhibition of Rac activity (50) . HA-1077 and Y-27638, which are two structurally unrelated Rho kinase inhibitors (26, 49) , effectively inhibited S1P-induced stress fiber formation in CHO-S1P 2 cells (Fig. 7) ; however, they were totally ineffective in preventing the S1P 2 -mediated inhibition of IGF I-directed cell migration (Fig. 6E ), Rac activation (Fig. 6F) , or membrane ruffling (Fig. 7) . In contrast, C3 toxin abolished the S1P 2 -mediated inhibition of IGF I-induced membrane ruffling (Fig.  7f) as well as induction of stress fiber formation (Fig. 7j) . S1P 2 mediates actin cytoskeletal changes in two ways through Rho: it inhibits membrane ruffling in IGF I-stimulated cells, and it stimulates stress fiber formation. These observations clearly indicate that inhibition of membrane ruffle formation requires a Rho-dependent signal other than the Rho kinase pathway, 12 -CT and G␣ 13 -CT, but not G␣ q -CT, abolishes S1P inhibition of IGF I-induced membrane ruffling and also S1P stimulation of stress fiber formation in S1P 2 receptor-expressing cells. CHO-S1P 2 cells were infected with adenoviruses encoding G␣ 12 -CT, G␣ 13 -CT, G␣ q -CT, or LacZ as for Fig. 3A . Cells were stimulated with IGF I (100 ng/ml) and/or S1P (10 Ϫ7 M) for 30 min. Cells were fixed, permeabilized, and stained with TRITC-labeled phalloidin for F-actin. 
FIG. 4. Expression of G␣
Overexpression of G␣ i counteracts AlF 4
؊ -and S1P-induced inhibition of Rac and migration. S1P 2 couples not only to G 12/13 but also to G i (13, 30, 49) . PTX pretreatment of CHO-S1P 2 cells potentiated S1P inhibition of chemotaxis (Fig. 1B) , suggesting that G i conveyed a signal which counteracted inhibition of migration. To study in more depth the role of G␣ i in the regulation of Rac and cell migration by the S1P receptor, we evaluated the effects of overexpression of G␣ i2 , which is an endogenously expressed G␣ i isoform in CHO cells, on AlF 4 Ϫ -and S1P-induced inhibition of Rac and migration in CHO-S1P 2 cells (Fig. 8) . In cells overexpressing G␣ i2 , S1P by itself stimulated chemotaxis and Rac moderately, unlike the situation in the vector control cells (data not shown). Overexpression of G␣ i2 nearly completely abolished AlF 4 Ϫ -and S1P-induced inhibition of chemotaxis ( Fig. 8B and C) . The results contrast sharply with those obtained with overexpression of either G␣ 12 or G␣ 13 , which potentiated AlF 4 Ϫ -and S1P-induced inhibition of IGF I-directed chemotaxis ( Fig. 8B and C) . Overexpression of G␣ q did not affect inhibition by AlF 4 Ϫ or S1P. In agreement with these observations on migration, overexpression of G␣ i2 nearly abolished S1P inhibition of IGF I-induced stimulation of Rac, whereas overexpression of G␣ 12 and G␣ 13 potentiated S1P inhibition of IGF I stimulation of Rac compared to that in vector control cells (Fig. 8D) . Expression of G␣ q did not affect S1P inhibition of Rac activity. Overexpression of these G␣ subunits did not affect chemotaxis or Rac activation in response to IGF I alone ( Fig. 8C and D) . Thus, G i generates a stimulatory signal for Rac and consequently migration to antagonize G 12/13 -mediated inhibition of Rac and migration in S1P receptor signaling. S1P 3 mediates S1P inhibition, rather than stimulation, of Rac and cell migration upon G i inactivation. As we reported previously (31) , S1P by itself directed chemotaxis in both S1P 1 -and S1P 3 -expressing CHO cells (CHO-S1P 1 and CHO-S1P 3 cells, respectively) ( Fig. 9A and B ). This contrasts with CHO-S1P 2 cells, in which S1P by itself does not stimulate chemotaxis (31) . PTX pretreatment of both CHO-S1P 1 and CHO-S1P 3 cells totally inhibited migration toward S1P, indicating that S1P-directed chemotaxis is G i/o dependent ( Fig. 9A and B) . When CHO-S1P 1 cells were stimulated with a combination of S1P and IGF I, they showed a chemotactic response slightly greater than that to stimulation with IGF I alone (Fig. 9C) . PTX pretreatment did not affect CHO-S1P 1 cell migration stimulated by IGF I alone, and it slightly reduced cell migration stimulated by the combination of S1P and IGF I. In CHO-S1P 3 cells, the combination of S1P and IGF I induced a stimulation of chemotaxis slightly larger than that with IGF I alone, as in CHO-S1P 1 cells (Fig. 9D) . PTX did not affect the response to IGF I alone in this cell type, either. In contrast to FIG. 5 . The fusion receptors S1P 2 -G␣ 12 and S1P 2 -G␣ 13 , but not S1P 2 -G␣ q , mediate inhibition of Rac and migration. (A) Coimmunoprecipitation of S1P 2 and either G 12 or G 13 . COS7 cells were transiently cotransfected with pCAGGS-FLAG-S1P 2 and either pCAGGS-G␣ 12 or pCAGGS-G␣ 13 , and FLAG-tagged S1P 2 was immunoprecipitated with an anti-FLAG (M2) antibody. The anti-FLAG immunoprecipitates were analyzed by Western blotting using anti-G 12 or anti-G 13 antibodies. Portions of cell lysates were analyzed by Western blotting using anti-FLAG, anti-G 12 , and anti-G 13 antibodies. TFX, transfection; IP, immunoprecipitation; IB, immunoblotting. (B) S1P inhibits IGF I-directed chemotaxis in CHO cells expressing S1P 2 -G␣ 12 and S1P 2 -G␣ 13 , but not S1P 2 -G␣ q or vector, which is sensitive to expression of G␣ 12 -CT and G␣ 13 -CT inhibitor peptides. CHO cells stably expressing S1P 2 -G␣ 12 , S1P 2 -G␣ 13 , or S1P 2 -G␣ q were infected with adenoviruses encoding G␣ 12 -CT, G␣ 13 -CT, or LacZ and then subjected to transwell migration as for 12 and S1P 2 -G␣ 13 , but not S1P 2 -G␣ q or vector. Cells were stimulated as described in the legend for Fig. 3B and C and were subjected to a pulldown assay for GTP-Rac and GTP-Rho.
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CHO-S1P 1 cells, however, inactivation of G i with PTX in CHO-S1P 3 cells dramatically changed the responses to S1P: the cells showed inhibition, rather than stimulation, of IGF I-directed chemotaxis in response to S1P, with a nearly complete inhibition at 10 Ϫ6 M (Fig. 9D) . Moreover, adenovirusmediated expression of either G␣ 12 -CT or G␣ 13 -CT abolished S1P inhibition of IGF I-directed chemotaxis in PTX-treated CHO-S1P 3 cells (Fig. 9D) .
In CHO-S1P 1 cells S1P by itself stimulated Rac, which was totally inhibited by PTX (Fig. 10A) . IGF I also stimulated Rac, but in a PTX-insensitive manner. The combination of S1P and IGF I induced a slightly but consistently greater response in Rac activation compared to that with stimulation by either alone. In CHO-S1P 3 cells S1P by itself stimulated Rac in a PTX-sensitive manner (Fig. 10C) , which was similar to the findings for CHO-S1P 1 cells. In contrast to the situation in PTX-pretreated CHO-S1P 1 cells, however, in PTX-pretreated CHO-S1P 3 cells S1P markedly inhibited IGF I-stimulation of Rac (Fig. 10C) , which was consistent with the S1P inhibition of IGF I-directed chemotaxis. Expression of either G␣ 12 -CT or G␣ 13 -CT abolished the S1P inhibition of Rac in PTX-pretreated, IGF I-stimulated CHO-S1P 3 cells (Fig. 10C) , just as with cell migration (Fig. 9D) . In CHO-S1P 3 cells, S1P induced 
FIG. 7.
Rho kinase inhibitors do not affect S1P inhibition of IGF I-induced membrane ruffling but do abolish S1P-induced stress fiber formation. CHO-S1P 2 cells were pretreated either with C3 toxin, as described in Materials and Methods, or with HA-1077 (20 M) or Y-27632 (10 M) for 30 min. Cells were then stimulated with IGF I (100 ng/ml) and/or S1P (10 Ϫ7 M) for 30 min. Cells were stained with TRITC-labeled phalloidin for F-actin. Note that C3, but not HA-1077 or Y-27632, abolishes S1P inhibition of membrane ruffling in response to IGF I, although the Rho kinase inhibitors effectively suppress S1P-induced stress fiber formation.
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G 12/13 -Rho MEDIATES Rac INHIBITION BY S1P 2 /Edg5 1541 stimulation of RhoA via G 12/13 irrespective of PTX pretreatment (Fig. 10D) . S1P did not change the level of GTP-RhoA in CHO-S1P 1 cells (Fig. 10B) . Thus, inactivation of G i in CHO-S1P 3 cells converts S1P-induced stimulation of Rac and migration to inhibition of Rac and migration. These observations indicate that the S1P receptor isoforms S1P 1 , S1P 2 , and S1P 3 exert distinct regulatory actions on Rac and cell migration through differential coupling to G 12/13 and G i , which convey signals to inhibit and stimulate Rac and migration, respectively.
DISCUSSION
Multiple classes of cell surface receptors including receptor tyrosine kinases and GPCRs trigger chemotactic behavior of cells (21, 36) . In GPCR-activated chemotactic signaling, liberation of ␤␥ subunits from the heterotrimeric G i , activation of phosphatidylinositol 3-kinases, and stimulation of the small GTPase Rac are considered to constitute the important signaling cascade for stimulating chemotaxis (15) . However, much less is known about signaling mechanisms of chemorepellant receptors. We recently identified S1P 2 as the first example of a GPCR that mediates negative regulation of Rac, which serves as a signal for inhibiting cell migration directed toward a chemoattractant (31, 33, 42) . In the present study, first, we observed that direct activation of heterotrimeric G proteins with AlF 4 Ϫ (17) mimicked all of the known S1P actions in S1P 2 receptor-expressing cells (Fig. 1A to D) , strongly
FIG. 8. Overexpression of G␣ i counteracts AlF 4
Ϫ -and S1P-induced inhibition of Rac and migration in S1P 2 receptor-expressing cells. (A) Western blot analysis of expression of full-length G␣ proteins. CHO-S1P 2 cells stably expressing either G␣ i2 , G␣ q , G␣ 12 , G␣ 13 , or an empty vector were subjected to Western blot analysis using respective, specific anti-G␣ antibodies described in Materials and Methods. (B and C) Overexpression of G␣ i markedly attenuates AlF 4 Ϫ -and S1P-induced inhibition of IGF I-directed chemotaxis, but overexpression of G␣ 12 or G␣ 13 enhances such inhibition. Transwell migration of the CHO-S1P 2 cells that stably express one of these G␣ subunits or the empty vector was determined as for Fig. 1A and 2B. (D) Overexpression of G␣ i markedly attenuates S1P inhibition of IGF I-induced Rac stimulation. CHO-S1P 2 cells that stably express one of the G␣ subunits or an empty vector were stimulated as for Fig. 3B and then subjected to a pulldown assay for GTP-Rac.
FIG. 9. PTX pretreatment abolishes S1P stimulation of migration in S1P 1 -and S1P 3 -expressing cells and uncovers S1P 3 -mediated, G 12/13 -dependent inhibition of IGF I-directed chemotaxis. (A and B) PTX pretreatment abolishes chemotaxis toward S1P in CHO-S1P 1 and CHO-S1P 3 cells. Cells were pretreated or not with PTX as described in Materials and Methods and were then subjected to a transwell migration assay in the presence of various concentrations of S1P in the lower chamber. (C and D) PTX pretreatment unveils S1P-induced, G 12/13 -dependent inhibition of IGF I-directed chemotaxis in CHO-S1P 3 cells, but not in CHO-S1P 1 cells. CHO-S1P 3 cells were infected with adenoviruses encoding G␣ 12 -CT, G␣ 13 -CT, and LacZ and were then pretreated or not with PTX, as for Fig. 3D . Cells were then subjected to a transwell migration assay as for Fig. 2B. suggesting that heterotrimeric G protein coupling mediates inhibition of Rac and migration downstream of S1P 2 stimulation. By utilizing specific G protein inhibitors (1, 11), we demonstrated that it is the G 12/13 family protein that couples S1P 2 to inhibition of Rac, cell migration, and membrane ruffling (Fig. 2B, 3, and 4) . Consistent with the critical roles of G 12/13 , the fusion receptors S1P 2 -G␣ 12 and S1P 2 -G␣ 13 , but not S1P 2 -G␣ q , mediated S1P inhibition of Rac and cell migration (Fig.  5) , and overexpression of either G␣ 12 or G␣ 13 , but not G␣ q , potentiated the inhibitory effects of S1P (Fig. 8) . In addition, the observation that expression of ␤ARK-CT, which sequesters ␤␥ subunits (20) , did not abolish S1P inhibition of migration but rather slightly augmented it suggests that G␣ 12 and G␣ 13 , but not ␤␥ subunits of G 12/13 , mediate S1P inhibition of migration (Fig. 2B) . It is of note that the metastin receptor hTOT7T175 and the thrombin receptor PAR1, which are GPCRs capable of inhibiting cell migration, are also G 12/13 coupled (18, 28) , although these receptors are not known to be able to inhibit Rac. However, the present study also indicates that GPCRs that couple to G 12/13 do not always inhibit Rac or cell migration (see below).
Since Rho is a well-established effector of the G 12/13 class of heterotrimeric G proteins (12), we next examined its involvement in the S1P 2 signaling leading to Rac inhibition. Inhibition of endogenous Rho activity by C3 toxin treatment or N 19 RhoA expression abolished G 12/13 -mediated inhibition of Rac, cell migration, and membrane ruffling (Fig. 6A, 6B, and 7) . Conversely, expression of V 14 Rho mimicked S1P inhibition of Rac and also of migration, like N 17 Rac expression ( Fig. 6C and D ). These observations, together with the observation that S1P 2 mediates Rho stimulation via G 12/13 ( Fig. 1 and 3 ) (31), clearly indicate that Rho mediates Rac inhibition. Although it was previously demonstrated that expression of V 14 Rho resulted in inhibition of cellular Rac activity (50) , this is the first demonstration that receptor activation of the G 12/13 -Rho signaling pathway mediates Rac inhibition. In certain cell types (6, 19) , G q as well as G 12/13 was demonstrated to mediate Rho stimulation. However, in CHO-S1P 2 cells, the G q inhibitor peptide did not affect S1P-induced Rho stimulation (Fig. 3B) . Besides the inhibitory action on cellular Rac activity, Rho may also act to inhibit cell motility through its stimulating effects on contractile actin-myosin filaments, which result in the formation of stress fibers and focal adhesions (2, 27) , although precise mechanisms relating these structures to inhibition of migration remain to be elucidated.
Rho kinase is a candidate Rho effector that mediates Rac inhibition. Indeed, a previous study showed that expression of V 14 Rho in PC12 cells inhibited nerve growth factor-induced activation of Rac and that this inhibition was reversed by the Rho kinase inhibitor Y-27632 (50) . It was also reported recently that Y-27632 inhibition of Rho kinase unveiled previously unrecognized Rho-dependent activation of Rac via mDia, which is another direct effector of Rho (45) . In contrast to these previous reports, however, we did not observe any prevention of S1P 2 -mediated inhibition of Rac, cell migration, or membrane ruffling by two structurally different Rho kinase inhibitors, Y-27632 and HA-1077, although they effectively inhibited S1P 2 -mediated, Rho-dependent stress fiber formation (Fig. 6E, 6F , and 7). Our results indicate that a Rho effector other than Rho kinase plays a critical role in S1P 2 receptor-mediated Rac inhibition. It is possible that the effects of activation of endogenous Rho by receptor stimulation and V 14 RhoA expression could be distinct both temporally and spatially, resulting in different effector stimulation. Although the exact explanation for the discrepancy is not known at present, these disparate observations suggest that there exist both Rho kinase-dependent and -independent mechanisms for Rho regulation of Rac activity. The differential effects of C3 toxin and the Rho kinase inhibitors on the actin cytoskeletal changes (Fig. 7) also indicate that the S1P 2 receptor stimulates Rho to mediate dissolution of membrane ruffles and induction of stress fiber formation, which are uncoupled processes, through Rho kinase-independent and -dependent pathways, respectively, in CHO cells.
Another point that should be noted in the present results is the counteraction between G 12/13 and G i with regard to Rac regulation. Thus, overexpression of G␣ i reversed S1P 2 -mediated, G 12/13 -dependent suppression of Rac and migration ( Fig.  8C and D) , like that of the G 12/13 inhibitor peptides. Moreover, we demonstrated in the present study that S1P 3 , an isoform of S1P 2 , exerts dual regulation for cellular Rac activity via G 12/13 and G i (Fig. 10C) . As we and others (31, 32) reported previously, S1P 3 as well as S1P 1 mediate G i -dependent stimulation of Rac activity and migration ( Fig. 9 and 10 ). S1P 1 couples exclusively to G i , whereas S1P 3 , like S1P 2 , couples to G q and G 12/13 in addition to G i (43, 49) . Inactivation of G i by PTX treatment uncovered S1P 3 -mediated, G 12/13 -dependent inhibitory regulation for Rac and migration ( Fig. 9D and 10C ). The S1P 2 receptor also couples to G i to activate ERK (Fig. 3D ) (13) ; however, this coupling appears to be less efficient than those of S1P 1 and S1P 3 , as evidenced by the fact that the dose-response curve for S1P-induced, G i -dependent ERK activation in CHO-S1P 2 cells is shifted at least 1 order rightward from that in S1P 1 -and S1P 3 -expressing cells (30) . Robust activation by S1P 2 of the G 12/13 -Rho pathway likely masks the FIG. 10 . PTX pretreatment abolishes S1P stimulation of Rac in S1P 1 -and S1P 3 -expressing cells and uncovers S1P 3 -mediated, G 12/13 -dependent inhibition of IGF I-induced Rac stimulation. (A and B) Effects of PTX pretreatment on Rac and Rho activities in CHO-S1P 1 cells. Cells were pretreated or not pretreated with PTX, stimulated with IGF I and/or S1P, and subjected to a pulldown assay for GTP-Rac and GTP-Rho, as described in the legends for Fig. 3B , C, and D. (C and D) Effects of PTX treatment and expression of G␣ 12 -CT and G␣ 13 -CT on Rac and Rho activities in CHO-S1P 3 cells. Cells were infected with adenoviruses encoding G␣ 12 -CT, G␣ 13 -CT, and LacZ and then pretreated or not with PTX, as for Fig. 3D . Cells were stimulated in the same way as for panels A and B and were subjected to a pulldown assay for GTP-Rac and GTP-Rho.
VOL. 23, 2003 G 12/13 -Rho MEDIATES Rac INHIBITION BY S1P 2 /Edg5 1543 G i -mediated, modest stimulatory effect on Rac, resulting in evident inhibition of cellular Rac activity and migration, even in naive CHO-S1P 2 cells (Fig. 1 to 3 ). Besides the S1P 2 and S1P 3 receptors, a number of GPCRs have been shown to couple to G i , G 12/13 , and also G q (18, 28, 39) . In certain cell types, G q as well as G 12/13 may transmit a stimulatory signal to Rho (6, 19) . It is likely that integration of G i -and G 12/13 -or G q -dependent, positive and negative regulatory signals for cellular Rac activity determines the eventual regulatory activities of the GPCRs with regard to cell migration.
